Rhythm Biosciences Ltd has released a press release.
RHY Continues Platform Expansion Program for Other Cancers
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Story so far
Earlier from Rhythm Biosciences
- MST Access Diagnostics Forum Presentation (Amended)
- MST Access Financial Diagnostics Presentation
- RHY 2022 AGM Presentation
- Healthcare Conference Investor Presentation
- ColoSTAT Authorised For Sale In New Zealand
Later from Rhythm Biosciences
- Market Update
- Institutional Presentation
- Appendix 4C - Quarterly
- RHY Institutional Presentation
- Appendix 4D & Interim Financial Report
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences